Surrozen Inc SRZN

US Biotechnology
$29.54 β–Ό -12.29% ($-4.14)
🔥 High Short Interest 🎈 Low Float
Open $34.72
Prev Close $33.68
Day Range $28.55 – $37.83
52W Range $11.39 – $35.86
Market Cap $347.20M
Beta 0.50
EPS (TTM) $-35.79

πŸ“‹ Company Profile

IndustryBiotechnology
CountryUS
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD
IPO Date2020-11-23
Shares Out.11,610,000
Websitesurrozen.com β†—
Phone13026587581
Employees44
Revenue$5.0M
Gross Profit$5.0M
Net Income$50.2M
Free Cash Flow-$35.0M
Total Assets$115.6M
Total Liabilities$334.3M
Equity-$218.7M
About Surrozen Inc

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).

Surrozen Inc is a publicly traded company under the ticker symbol SRZN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.

πŸ“Š Analyst Ratings

12 analysts (2026-09-01)

Strong Buy 4
Buy 7
Hold 1

πŸ“° Latest News for SRZN

πŸ‘₯ Related Stocks